10 results about "Stachyose hydrate" patented technology

This invention relates to the field of sports nutrition food technology, and discloses a multivitamin formula and its preparation method, comprising the following components in parts by weight: 1.8-2.2 parts of mannose oligosaccharide, 1.8-2.2 parts of galacose oligosaccharide, 9-11 parts of xylooligosaccharide, 6.5-7.5 parts of fructooligosaccharide, 8.5-9.5 parts of maltitol, 1.8-2.2 parts of erythritol, 2.8-3.2 parts of galacose-mannan, 1.8-2.2 parts of stachyose, 13-15 parts of inulin, 38-42 parts of resistant dextrin, 0.20-0.24 parts of vitamin C, 0.45-0.55 parts of silicon dioxide, 0.010-0.014 parts of vitamin B1, and vitamin B2. 0.005-0.007 parts, folic acid 0.0009-0.0011 parts, γ-aminobutyric acid 0.45-0.55 parts, tyrosine 3.8-4.2 parts, magnesium lactate 3.8-4.2 parts; This invention forms a complex prebiotic system by simultaneously adding eight kinds of dietary fiber / oligosaccharides: resistant dextrin, inulin, xylooligosaccharide, fructooligosaccharide, galactooligosaccharide, mannose, galactomannan, and stachyose, which comprehensively regulates the intestinal flora and promotes the production of short-chain fatty acids.

The present application provides a nutrient composition including: stachydrine, lactobacillus plantarum, walnut peptide, desert cistanche, casein hydrolysate, and two or more of theanine. The present inventors found that the above nutrient composition has a brain health function in the direction of anxiolytic, antioxidant, neuroprotective, and memory improvement.

The application discloses a kind of oligosaccharide particles containing xylitol and a preparation method thereof, and relates to the technical field of oligosaccharide particle preparation, comprising the following raw materials: fructooligosaccharide powder, xylitol, modified resistant dextrin, modified stachyose, modified zein, anti-caking agent, deionized water, microcrystalline cellulose and binder forming agent.In the application, modified resistant dextrin is added, which forms a hydrophobic protective layer on the surface, effectively preventing the particle from absorbing moisture, sticking and caking, and prolonging the shelf life of the particle.The modified resistant dextrin can support the structure of the particle, reduce breakage, and ensure smooth cold water solubility, balancing the stability and solubility of the particle, and solving the pain points of pure oligosaccharide particles, such as moisture absorption and breakage.Modified stachyose is added, which can significantly reduce the intestinal irritation of prebiotics and avoid abdominal distension caused by rapid fermentation of ordinary stachyose.Meanwhile, the modified stachyose can synergistically act with fructooligosaccharide to strengthen the intestinal care effect and adapt to people with sensitive stomachs.

The present invention discloses the use of stachyose in the preparation of a drug for treating castration-resistant prostate cancer, which belongs to the field of biomedicine. The present invention is the first to propose a new strategy for combining stachyose with androgen receptor antagonists to prepare a drug for treating CRPC, and conducts multifaceted and multi-stage validation research. The pharmaceutical composition of the present invention combining stachyose with androgen receptor can be used to treat castration-resistant prostate cancer, which can significantly improve the inhibitory effect of enzalutamide on castration-resistant prostate cancer, and the application of natural compounds to late-stage cancer is of great significance in clinical treatment.

A solid cannabinoid composition comprising: (i) 0.3 to 10% by weight of one or more cannabinoids; (ii) 4 to 69% by weight of one or more nonionic surfactants having an HLB value of 10 to 25; (iii) at least 20% by weight of one or more carbohydrates selected from mannitol, sucrose, trehalose, and stachyose; and (iv) 0 to 5% by weight of water, wherein the combination of one or more nonionic surfactants and one or more carbohydrates accounts for at least 70% by weight of the composition. A sterile aqueous solution for use in medical treatment, comprising: (a) 0.1 to 10 mg / mL of one or more cannabinoids; (b) one or more nonionic surfactants having an HLB value of 10 to 25; (c) one or more carbohydrates selected from mannitol, sucrose, trehalose, and stachyose; and (d) at least 85% by weight of water, wherein one or more nonionic surfactants and one or more cannabinoids are present in the sterile aqueous solution in a weight ratio of 3:1 to 30:1, and one or more carbohydrates and one or more cannabinoids are present in the sterile aqueous solution in a weight ratio of 3:1 to 300:1.

The application discloses a use of a pharmaceutical composition consisting of berberine hydrochloride and stachydrine in regulating intestinal flora of animals, and belongs to the technical field of medicines. The composition can selectively increase the number of a part of beneficial bacteria in the intestines of animals, and improve the structure of intestinal flora. In particular, the number of Akkermansia muciniphila in the intestines of animals can be significantly increased, and then the intestinal barrier function is improved through the regulating effect of intestinal flora, so that diseases such as obesity, diabetes, hyperlipidemia and the like are prevented or treated.

This invention discloses a high-pressure homogenization coupled with spray drying process for liposome preparation, belonging to the field of pharmaceutical preparation technology. The process includes the following steps: dissolving active ingredients, phospholipids, and cholesterol in an organic solvent and hydrating them to form a suspension; homogenizing the suspension under high pressure to obtain a homogenized solution; adding a glassy protective agent, chitosan, and thixotropic silica gel to the homogenized solution and mixing to obtain a composite solution; the glassy protective agent includes asiaticoside and stachyose; and subjecting the composite solution to gradient cooling spray drying to obtain liposomes. This invention, through high-pressure homogenization and the synergistic effect of the glassy protective agent composed of asiaticoside and stachyose, chitosan, and thixotropic silica gel, forms a multi-level synergistic protection during gradient cooling spray drying, significantly improving the rehydration integrity of liposomes, the long-term storage stability of active ingredients, and photostability.

This invention relates to a composition for repairing skin barrier damage in sensitive skin and its application, belonging to the field of cosmetic technology. The composition for repairing skin barrier damage of this invention comprises the following components: stachyose, 1,3-propanediol, lecithin, silymarin, and sennaol. The composition for repairing skin barrier damage of this invention has significant repairing and moisturizing effects and is suitable for sensitive skin.